Literature DB >> 17283191

Species-specific differences in the susceptibilities of biofilms formed by Candida bloodstream isolates to echinocandin antifungals.

Hyun Woo Choi1, Jong Hee Shin, Sook In Jung, Kyung Hwa Park, Duck Cho, Seung Jung Kee, Myung Geun Shin, Soon Pal Suh, Dong Wook Ryang.   

Abstract

The echinocandin susceptibilities of bloodstream Candida isolates growing in a biofilm was investigated. Within the therapeutic range of concentrations of each drug, caspofungin and micafungin were active against biofilms formed by Candida albicans or C. glabrata but not those formed by C. tropicalis or C. parapsilosis.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17283191      PMCID： PMC1855493          DOI： 10.1128/AAC.01141-06

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  16 in total

Review 1.  Candida biofilms: antifungal resistance and emerging therapeutic options.

Authors:  Duncan M Kuhn; Mahmoud A Ghannoum
Journal:  Curr Opin Investig Drugs       Date:  2004-02

2.  Risk factors for candidal bloodstream infections in surgical intensive care unit patients: the NEMIS prospective multicenter study. The National Epidemiology of Mycosis Survey.

Authors:  H M Blumberg; W R Jarvis; J M Soucie; J E Edwards; J E Patterson; M A Pfaller; M S Rangel-Frausto; M G Rinaldi; L Saiman; R T Wiblin; R P Wenzel
Journal:  Clin Infect Dis       Date:  2001-06-20       Impact factor: 9.079

3.  Comparison of biofilms formed by Candida albicans and Candida parapsilosis on bioprosthetic surfaces.

Authors:  D M Kuhn; J Chandra; P K Mukherjee; M A Ghannoum
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

4.  In vitro pharmacodynamic properties of three antifungal agents against preformed Candida albicans biofilms determined by time-kill studies.

Authors:  Gordon Ramage; Kacy VandeWalle; Stefano P Bachmann; Brian L Wickes; José L López-Ribot
Journal:  Antimicrob Agents Chemother       Date:  2002-11       Impact factor: 5.191

5.  Antifungal activity of amphotericin B, fluconazole, and voriconazole in an in vitro model of Candida catheter-related bloodstream infection.

Authors:  Russell E Lewis; Dimitrios P Kontoyiannis; Rabih O Darouiche; Issam I Raad; Randall A Prince
Journal:  Antimicrob Agents Chemother       Date:  2002-11       Impact factor: 5.191

6.  In vitro activity of caspofungin against Candida albicans biofilms.

Authors:  Stefano P Bachmann; Kacy VandeWalle; Gordon Ramage; Thomas F Patterson; Brian L Wickes; John R Graybill; José L López-Ribot
Journal:  Antimicrob Agents Chemother       Date:  2002-11       Impact factor: 5.191

7.  Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms.

Authors:  G Ramage; K Vande Walle; B L Wickes; J L López-Ribot
Journal:  Antimicrob Agents Chemother       Date:  2001-09       Impact factor: 5.191

8.  Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins.

Authors:  D M Kuhn; T George; J Chandra; P K Mukherjee; M A Ghannoum
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

9.  Biofilm production by isolates of Candida species recovered from nonneutropenic patients: comparison of bloodstream isolates with isolates from other sources.

Authors:  Jong Hee Shin; Seung Jung Kee; Myung Geun Shin; Soo Hyun Kim; Dong Hyeon Shin; Sang Ku Lee; Soon Pal Suh; Dong Wook Ryang
Journal:  J Clin Microbiol       Date:  2002-04       Impact factor: 5.948

10.  In vitro activities of voriconazole, posaconazole, and fluconazole against 4,169 clinical isolates of Candida spp. and Cryptococcus neoformans collected during 2001 and 2002 in the ARTEMIS global antifungal surveillance program.

Authors:  M A Pfaller; S A Messer; L Boyken; R J Hollis; C Rice; S Tendolkar; D J Diekema
Journal:  Diagn Microbiol Infect Dis       Date:  2004-03       Impact factor: 2.803
View more
  22 in total

1.  In vitro activity of micafungin against planktonic and sessile Candida albicans isolates.

Authors:  Melissa J Jacobson; Kathryn E Steckelberg; Kerryl E Piper; James M Steckelberg; Robin Patel
Journal:  Antimicrob Agents Chemother       Date:  2009-03-23       Impact factor: 5.191

2.  In vitro activity of anidulafungin against Candida albicans biofilms.

Authors:  Melissa J Jacobson; Kerryl E Piper; Gary Nguyen; James M Steckelberg; Robin Patel
Journal:  Antimicrob Agents Chemother       Date:  2008-04-07       Impact factor: 5.191

3.  In vitro assessment of the antifungal and paradoxical activity of different echinocandins against Candida tropicalis biofilms.

Authors:  Tsun Sheng N Ku; Stella M Bernardo; Samuel A Lee
Journal:  J Med Microbiol       Date:  2011-06-23       Impact factor: 2.472

4.  In vitro activities of anidulafungin and other antifungal agents against biofilms formed by clinical isolates of different Candida and Aspergillus species.

Authors:  Barbara Fiori; Brunella Posteraro; Riccardo Torelli; Mario Tumbarello; David S Perlin; Giovanni Fadda; Maurizio Sanguinetti
Journal:  Antimicrob Agents Chemother       Date:  2011-03-21       Impact factor: 5.191

Review 5.  Resistance of Candida spp. to antifungal drugs in the ICU: where are we now?

Authors:  Danièle Maubon; Cécile Garnaud; Thierry Calandra; Dominique Sanglard; Muriel Cornet
Journal:  Intensive Care Med       Date:  2014-08-05       Impact factor: 17.440

6.  In vitro effect of amphotericin B on Candida albicans, Candida glabrata and Candida parapsilosis biofilm formation.

Authors:  Małgorzata Prażyńska; Eugenia Gospodarek
Journal:  Mycopathologia       Date:  2014-01-17       Impact factor: 2.574

7.  Fungal Biofilms: Relevance in the Setting of Human Disease.

Authors:  Luis R Martinez; Bettina C Fries
Journal:  Curr Fungal Infect Rep       Date:  2010-12-01

Review 8.  Echinocandin antifungal drugs in fungal infections: a comparison.

Authors:  Sharon C-A Chen; Monica A Slavin; Tania C Sorrell
Journal:  Drugs       Date:  2011-01-01       Impact factor: 9.546

9.  Species-specific and drug-specific differences in susceptibility of Candida biofilms to echinocandins: characterization of less common bloodstream isolates.

Authors:  Maria Simitsopoulou; Pavla Peshkova; Efthymia Tasina; Aspasia Katragkou; Daniela Kyrpitzi; Aristea Velegraki; Thomas J Walsh; Emmanuel Roilides
Journal:  Antimicrob Agents Chemother       Date:  2013-03-25       Impact factor: 5.191

10.  Activities and ultrastructural effects of antifungal combinations against simulated Candida endocardial vegetations.

Authors:  Manjunath P Pai; Marie L Samples; Renee-Claude Mercier; Michael N Spilde
Journal:  Antimicrob Agents Chemother       Date:  2008-04-21       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.